Rick Osterberg’s connection to Swim Across America was initiated similarly to that of so many other members of the Swim Across America community. It’s his journey over the last six years that sets him apart from many other participants.

Rick and his wife, Jessica Stokes, are lifelong swimmers, both swimming competitively in college and continuing to swim as USMS masters swimmers. They met during Masters workouts at Harvard University nearly 25 years ago. Their involvement with Swim Across America began about 15 years ago when they heard about the organization and knew many people involved in the Swim Across America – Boston community swim. 

Although he admits that Jessica is the more dedicated swimmer, Rick has played several roles over the years eventually leading to a role on the local leadership committee for Swim Across America – Boston. 

“I was an occasional walk-up volunteer for the Swim Across America – Nantasket swim whenever Jess was swimming it,” said Rick. 

“I got much more involved when we launched the Swim Across America – Boston Relay Challenge at Harvard in 2012, acting as the emcee, DJ, and scoreboard person.” 

Rick remained a volunteer with Swim Across America – Boston for several years and took on an official role on the local committee in 2018. Jessica is also on the committee and leads their relationship with their beneficiaries, Dana-Farber Cancer Institute and MassGeneral Children’s Cancer Center. 

Their involvement took on more purpose in 2018, when Rick received a diagnosis of stage three colon cancer. While this deepened their connection to the Swim Across America mission, Rick didn’t see anything particularly extraordinary about his treatment plan.

“In 2018, my perspective and Jess’ perspective on Swim Across America changed when I was diagnosed with stage three colon cancer. Suddenly, I was a patient. In 2018, I felt a much deeper connection to the overall mission of SAA, but not necessarily to any particular SAA beneficiary,” said Rick.

Rick’s diagnosis was, in his words, rather traditional though he was moved by the amount of support within his SAA-Boston community that year.

“It was deeply humbling to attend the 2018 Boston pool relay, during chemotherapy, and see so many people who were swimming for me,” said Rick. 

“That event in 2018 remains one of the most moving experiences of my cancer journey. It was a huge boost to me, and a huge boost to Jess, during one of the harder phases of that treatment process. It also helped to turn a difficult experience into a hopeful direction through fundraising.”

Rick spent 2018 battling cancer with Jess at his side. He went through chemotherapy, chemo-radiation therapy, and finally surgery, and was in full remission by the end of the year. 

They both looked forward to the April 2019 Swim Across America – Boston pool relay with Rick resuming his usual responsibilities as emcee and DJ. He added another “role” to his list that day – cancer success story. 

“I had beaten it, which was a great reason for many people to come and swim. It was an incredibly moving day and special because it ended up being our last pool relay before COVID,” said Rick.

The COVID-19 pandemic halted in-person events for 2020, which meant Rick and Jessica would miss out on the SAA-Boston event. Rick kept up with his routine scans and in June 2020, scans detected a small growth on a lymph node indicating his cancer had returned. Fortunately for Rick, FDA approval of a new immunotherapy drug had just been announced and it seemed like Rick was a great candidate for this new treatment.

“Suddenly, I was a candidate for Keytruda,” said Rick. “And the KEYNOTE-177 clinical trial results changed my cancer trajectory.”

“At this point, I’m now a Keytruda patient. I have virtually zero side-effects, and I have an incredibly high quality of life.”

Thanks to this new immunotherapy treatment, Rick’s cancer is virtually eliminated. He has avoided further surgical intervention that could carry significant risk of serious side effects or lower quality of life.

Rick’s commitment to Swim Across America was deepened when he realized the connection between the organization and the clinical trials that led to Keytruda’s FDA approval. The Swim Across America – Baltimore community swim benefits Johns Hopkins Medicine and grants from the 2015, 2016, and 2017 events funded groundbreaking research in immunotherapies, specifically PD-1 inhibitors. This research led to the FDA approval of Keytruda.

“After being part of an organization for so long, I was now a direct beneficiary of the research funded by SAA. I am one of a cohort of cancer patients who has experienced the necessary awfulness of chemotherapy, and the dramatically different journey on immunotherapy therapies,” shared Rick.

“I have been on my cancer journey for more than 6 years now, and in that short time, I have seen so many breakthroughs in treatment, but I also see so many cases where better options  are needed for friends whose treatment paths are much more difficult than mine has been.”

Rick feels incredibly fortunate to be where he is on his cancer journey, thanks in part to research funded by Swim Across America. He feels hopeful about the next big breakthrough that will give hope to more patients and their families.

When reflecting on the vast differences between how his cancer was treated, Rick underscores his remarkably high quality of life, and why he and Jessica continue to support Swim Across America.

“Due in large part to research funded by Swim Across America, my cancer journey right now is not much more than an appointment on the calendar. My quality of life in treatment is virtually 100%,” said Rick. 

“Perhaps more importantly our cancer journey (including Jess) is no big deal right now. Our quality of shared life is virtually 100%. That’s difficult to appreciate unless you’ve been through chemotherapy, or have been a close supporter of someone going through chemotherapy.”

Combined and over the years, Rick and Jessica have raised over $156,000 for Swim Across America.

If you are moved to support Rick and Jessica, click here.